title: Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.
abstract: A single mechanism of azole resistance was shown to predominate in clinical and environmental Aspergillus fumigatus isolates from the Netherlands, and a link to the use of azoles in the environment was suggested. To explore the prevalence of azole-resistant A. fumigatus and other aspergilli in the environment in other European countries, we collected samples from the surroundings of hospitals in Copenhagen, Innsbruck, and Madrid, flowerbeds in an amusement park in Copenhagen, and compost bags purchased in Austria, Denmark, and Spain and screened for azole resistance using multidish agars with itraconazole, voriconazole, and posaconazole. EUCAST method E.DEF 9.1 was used to confirm azole resistance. The promoter and entire coding sequence of the cyp51A gene were sequenced to identify azole-resistant A. fumigatus isolates. A. fumigatus was recovered in 144 out of 185 samples (77.8%). Four A. fumigatus isolates from four Danish soil samples displayed elevated azole MICs (8%), and all harbored the same TR/L98H mutation of cyp51A. One A. lentulus isolate with voriconazole MIC of 4 mg/liter was detected in Spain. No azole-resistant aspergilli were detected in compost. Finally, A. terreus was present in seven samples from Austria. Multi-azole-resistant A. fumigatus is present in the environment in Denmark. The resistance mechanism is identical to that of environmental isolates in the Netherlands. No link to commercial compost could be detected. In Spain and Austria, only Aspergillus species with intrinsic resistance to either azoles or amphotericin B were found.
authors.affiliation: Mycology Unit, Department of Microbiological Surveillance and Research, Statens Serum Institut, Artillerivej 5, Copenhagen S, Denmark. klm@ssi.dk
authors.forename: Klaus Leth
authors.initials: KL
authors.lastname: Mortensen
authors.forename: Emilia
authors.initials: E
authors.lastname: Mellado
authors.forename: Cornelia
authors.initials: C
authors.lastname: Lass-Flörl
authors.forename: Juan Luis
authors.initials: JL
authors.lastname: Rodriguez-Tudela
authors.forename: Helle Krogh
authors.initials: HK
authors.lastname: Johansen
authors.forename: Maiken Cavling
authors.initials: MC
authors.lastname: Arendrup
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology*; D001232:Aspergillus fumigatus / Q000187:drug effects* / Q000302:isolation & purification*; D001317:Austria; D001393:Azoles / Q000494:pharmacology*; D003718:Denmark; D025141:Drug Resistance, Fungal; D004783:Environmental Microbiology; D017964:Itraconazole / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D011743:Pyrimidines / Q000494:pharmacology; D013030:Spain; D014230:Triazoles / Q000494:pharmacology; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D001393:Azoles; D011743:Pyrimidines; D014230:Triazoles; D017964:Itraconazole; C101425:posaconazole; D065819:Voriconazole
references.citation: Antimicrob Agents Chemother. 2004 Jul;48(7):2747-50
references.pmid: 15215142
references.citation: Trends Microbiol. 2001 Aug;9(8):382-9
references.pmid: 11514221
references.citation: Antimicrob Agents Chemother. 2005 Jun;49(6):2536-8
references.pmid: 15917566
references.citation: Antimicrob Agents Chemother. 2008 Apr;52(4):1244-51
references.pmid: 18212093
references.citation: Clin Infect Dis. 2001 Dec 1;33(11):1824-33
references.pmid: 11692293
references.citation: Antimicrob Agents Chemother. 2003 Mar;47(3):1120-4
references.pmid: 12604551
references.citation: Antimicrob Agents Chemother. 2008 Jul;52(7):2468-72
references.pmid: 18474574
references.citation: Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S265-80
references.pmid: 12975754
references.citation: Clin Microbiol Infect. 2010 Jun;16(6):683-8
references.pmid: 19673966
references.citation: Antimicrob Agents Chemother. 2003 Feb;47(2):577-81
references.pmid: 12543662
references.citation: Br J Haematol. 2005 Oct;131(2):201-7
references.pmid: 16197450
references.citation: J Clin Microbiol. 2001 Jul;39(7):2431-8
references.pmid: 11427550
references.citation: J Antimicrob Chemother. 2005 Jan;55(1):31-7
references.pmid: 15563516
references.citation: Drug Resist Updat. 2009 Dec;12(6):141-7
references.pmid: 19879181
references.citation: Clin Microbiol Infect. 2008 Oct;14(10):982-4
references.pmid: 18828858
references.citation: J Clin Microbiol. 2008 Aug;46(8):2568-72
references.pmid: 18562581
references.citation: J Clin Microbiol. 2009 Oct;47(10):3142-6
references.pmid: 19692559
references.citation: Emerg Infect Dis. 2009 Jul;15(7):1068-76
references.pmid: 19624922
references.citation: J Clin Microbiol. 2010 Apr;48(4):1478-80
references.pmid: 20107096
references.citation: Antimicrob Agents Chemother. 2001 Nov;45(11):2987-90
references.pmid: 11600346
references.citation: Med Mycol. 2005 May;43 Suppl 1:S307-11
references.pmid: 16110825
references.citation: Lancet Infect Dis. 2009 Dec;9(12):789-95
references.pmid: 19926038
references.citation: N Engl J Med. 2007 Apr 5;356(14):1481-3
references.pmid: 17409336
references.citation: Med Mycol. 2009;47 Suppl 1:S42-6
references.pmid: 19291598
references.citation: J Clin Microbiol. 2010 Sep;48(9):3251-7
references.pmid: 20592159
references.citation: Nat Rev Microbiol. 2005 Jul;3(7):547-56
references.pmid: 15953931
references.citation: Int J Antimicrob Agents. 2007 Jan;29(1):108-11
references.pmid: 17189101
references.citation: Clin Infect Dis. 2008 Feb 1;46(3):327-60
references.pmid: 18177225
references.citation: Appl Environ Microbiol. 2009 Jun;75(12):4053-7
references.pmid: 19376899
references.citation: Int J Antimicrob Agents. 2006 Nov;28(5):450-3
references.pmid: 17034993
references.citation: Antimicrob Agents Chemother. 2007 Jun;51(6):1897-904
references.pmid: 17371828
references.citation: PLoS Med. 2008 Nov 11;5(11):e219
references.pmid: 18998768